530233 — Auro Laboratories Income Statement
0.000.00%
- IN₹1.47bn
- IN₹1.72bn
- IN₹536.35m
- 69
- 26
- 80
- 65
Annual income statement for Auro Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 438 | 543 | 509 | 529 | 536 |
Cost of Revenue | |||||
Gross Profit | 193 | 257 | 181 | 172 | 271 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 387 | 440 | 473 | 496 | 441 |
Operating Profit | 51.4 | 102 | 36.1 | 33.2 | 95.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 56.4 | 105 | 38.7 | 34.5 | 103 |
Provision for Income Taxes | |||||
Net Income After Taxes | 40.5 | 71.8 | 28.4 | 24.4 | 77.9 |
Net Income Before Extraordinary Items | |||||
Net Income | 40.5 | 71.8 | 28.4 | 24.4 | 77.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 40.5 | 71.8 | 28.4 | 24.4 | 77.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.51 | 11.5 | 4.56 | 3.92 | 12.5 |